A positive surprise is on the way: Rocket Pharmaceuticals Inc (RCKT) Stock

Cantor Fitzgerald raised the price target for the Rocket Pharmaceuticals Inc (NASDAQ:RCKT) stock to “an Overweight”. The rating was released on October 24, 2023, according to finviz. The research report from Canaccord Genuity has initiated the stock to Buy, with a price target set at $53. The stock was initiated by BTIG Research, who disclosed […]

Investing in Rocket Pharmaceuticals Inc (RCKT) Stock: Methodology

Cantor Fitzgerald raised the price target for the Rocket Pharmaceuticals Inc (NASDAQ:RCKT) stock to “an Overweight”. The rating was released on October 24, 2023, according to finviz. The research report from Canaccord Genuity has initiated the stock to Buy, with a price target set at $53. The stock was initiated by BTIG Research, who disclosed […]

Would Rocket Pharmaceuticals Inc (RCKT) Stock like to attract the attention of traders?

Cantor Fitzgerald raised the price target for the Rocket Pharmaceuticals Inc (NASDAQ:RCKT) stock to “an Overweight”. The rating was released on October 24, 2023, according to finviz. The research report from Canaccord Genuity has initiated the stock to Buy, with a price target set at $53. The stock was initiated by BTIG Research, who disclosed […]

Rocket Pharmaceuticals Inc (NASDAQ:RCKT) Stock Reported EPS of -$0.64 in Last Quarter

Cantor Fitzgerald raised the price target for the Rocket Pharmaceuticals Inc (NASDAQ:RCKT) stock to “an Overweight”. The rating was released on October 24, 2023, according to finviz. The research report from Canaccord Genuity has initiated the stock to Buy, with a price target set at $53. The stock was initiated by BTIG Research, who disclosed […]

What is happening with Rocket Pharmaceuticals Inc (RCKT) Stock?

Cantor Fitzgerald raised the price target for the Rocket Pharmaceuticals Inc (NASDAQ:RCKT) stock to “an Overweight”. The rating was released on October 24, 2023, according to finviz. The research report from Canaccord Genuity has initiated the stock to Buy, with a price target set at $53. The stock was initiated by BTIG Research, who disclosed […]

Rocket Pharmaceuticals Inc (NASDAQ:RCKT) Stock is trading Higher 31.36% From 200-Day SMA

Cantor Fitzgerald raised the price target for the Rocket Pharmaceuticals Inc (NASDAQ:RCKT) stock to “an Overweight”. The rating was released on October 24, 2023, according to finviz. The research report from Canaccord Genuity has initiated the stock to Buy, with a price target set at $53. The stock was initiated by BTIG Research, who disclosed […]

Does Rocket Pharmaceuticals Inc (RCKT) Stock have plenty of room for growth?

Cantor Fitzgerald raised the price target for the Rocket Pharmaceuticals Inc (NASDAQ:RCKT) stock to “an Overweight”. The rating was released on October 24, 2023, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report as stock […]

Rocket Pharmaceuticals Inc (NASDAQ:RCKT) Stock is trading Above 6.11% From 50-Day SMA

Cantor Fitzgerald raised the price target for the Rocket Pharmaceuticals Inc (NASDAQ:RCKT) stock to “an Overweight”. The rating was released on October 24, 2023, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report as stock […]

Why Rocket Pharmaceuticals Inc (NASDAQ:RCKT) Stock Decreased -2.16 percent in recent Trade?

Cantor Fitzgerald raised the price target for the Rocket Pharmaceuticals Inc (NASDAQ:RCKT) stock to “an Overweight”. The rating was released on October 24, 2023, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report as stock […]